# OnCo record paper-zebra-pembrolizumab-small-bowel-adenocarcinoma-ccr-2021 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-zebra-pembrolizumab-small-bowel-adenocarcinoma-ccr-2021/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-zebra-pembrolizumab-small-bowel-adenocarcinoma-ccr-2021" ;
  schema:name "ZEBRA: pembrolizumab in advanced small bowel adenocarcinoma"@en ;
  schema:description "Immunotherapy on its own helped only a few patients with advanced small bowel adenocarcinoma, mainly those whose tumours had mismatch repair deficiency, so the drug is reserved for that group."@en ;
  schema:url <https://onco.cc/key-papers/paper-zebra-pembrolizumab-small-bowel-adenocarcinoma-ccr-2021/> ;
  schema:dateModified "2026-09-18"^^xsd:date ;
  schema:citation <https://doi.org/10.1158/1078-0432.CCR-21-0159>, <https://pubmed.ncbi.nlm.nih.gov/33883178/> ;
  schema:sameAs <https://doi.org/10.1158/1078-0432.CCR-21-0159> ;
  schema:datePublished "2021"^^xsd:gYear ;
  schema:author "Pedersen KS, Foster NR, Overman MJ, et al." ;
  onco:cancers <https://onco.cc/cancers/advanced-small-bowel-adenocarcinoma/> ;
  onco:drugs <https://onco.cc/drugs/pembrolizumab/> ;
  onco:journals <https://onco.cc/journals/clinical-cancer-research/> .